480 PLEASANT STREET, WATERTOWN, MA
Market cap: $1.1B (2/10/2026)
Price: $12.85
Reports Corporate Update and Anticipated Pivotal Milestones for 2026
EyePoint Pharmaceuticals Changes Name to EyePoint, Inc. Effective December 8,...
Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration
EyePoint Pharmaceuticals Files $200 Million Common Stock Prospectus Supplement
Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments
Announces Pricing of Public Offering
Investor Presentation
Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Developments
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Notice of Proposed Sale of Securities
Correspondence